TY - JOUR
T1 - Pulmonary Hypertension in Congenital Heart Disease
T2 - A Scientific Statement From the American Heart Association
AU - Jone, Pei Ni
AU - Ivy, D. Dunbar
AU - Hauck, Amanda
AU - Karamlou, Tara
AU - Truong, Uyen
AU - Coleman, Ryan D.
AU - Sandoval, Juan Pablo
AU - Del Cerro Marín, María Jesús
AU - Eghtesady, Pirooz
AU - Tillman, Kathryn
AU - Krishnan, Usha S.
N1 - Publisher Copyright:
© 2023 American Heart Association, Inc.
PY - 2023/7/1
Y1 - 2023/7/1
N2 - Patients with pulmonary hypertension associated with congenital heart disease make up an increasing proportion of the total pulmonary hypertension population who bring with them added complexity because of underlying anatomical and hemodynamic abnormalities. Currently, no consensus recommendations are available on how to best manage this group of patients for either the primary cardiologist or pulmonary hypertension subspecialist, including timing of referral. The purposes of this document are (1) to describe the various pulmonary hypertension groups and subgroups associated with congenital heart disease, (2) to describe imaging modalities used in patient evaluation, (3) to elucidate medical and surgical management considerations, (4) to highlight disparities within this population, and (5) to identify gaps and future research needs of patients with pulmonary hypertension associated with congenital heart disease.
AB - Patients with pulmonary hypertension associated with congenital heart disease make up an increasing proportion of the total pulmonary hypertension population who bring with them added complexity because of underlying anatomical and hemodynamic abnormalities. Currently, no consensus recommendations are available on how to best manage this group of patients for either the primary cardiologist or pulmonary hypertension subspecialist, including timing of referral. The purposes of this document are (1) to describe the various pulmonary hypertension groups and subgroups associated with congenital heart disease, (2) to describe imaging modalities used in patient evaluation, (3) to elucidate medical and surgical management considerations, (4) to highlight disparities within this population, and (5) to identify gaps and future research needs of patients with pulmonary hypertension associated with congenital heart disease.
KW - AHA Scientific Statements
KW - congenital heart disease
KW - pediatric pulmonary hypertension
KW - prognosis
KW - pulmonary arterial hypertension
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85165276597&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165276597&partnerID=8YFLogxK
U2 - 10.1161/HHF.0000000000000080
DO - 10.1161/HHF.0000000000000080
M3 - Review article
C2 - 37357777
AN - SCOPUS:85165276597
SN - 1941-3289
VL - 16
JO - Circulation: Heart Failure
JF - Circulation: Heart Failure
IS - 7
M1 - e00080
ER -